• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

US Study Examines Impact of Technology Use on Sleep Disorders


An analysis finds Americans who are under the age of 25, shift workers, and living in urban areas are more likely to have sleep disorders.

In recent years, the impact of technology usage on sleep has become of increasing concern, particularly among children and adolescents. Conversely, the emergence of smart beds and mattresses, as well as sleep apps, have provided a benefit for those with sleep disorders.

Researchers from SleepStandards.com sought to examine the utilization of technology in those with sleep disorders across age groups. Beginning at the end of July 2020, the study authors conducted a national survey of 1062 US participants, with the primary objective being to assess both negative and positive aspects of the connection between technology use and sleep disorders.

The survey was weighted to represent 5 distinct age groups:

  • Generation Z (ages under 25): 22.3%
  • Millennials (ages 26-40): 44.8%
  • Generation X (ages 41-55): 23.8%
  • Baby Boomers (ages 56-76): 8.9%
  • Silent generation (ages over 76): 0.2%

In the overall study findings, 71.8% of Americans with sleep disorders reported technology use before bed each night. Watching TV was indicated as the most favorite activity that Americans do 30 minutes before going to bed (70.2%), followed by checking social media (59.4%), checking emails (31.8%), and playing video games (32.9%).

When stratifying by age, those younger than 25 years were found to be at the highest risk of having sleep disorders (73.4%). Sleep problems were also prominent in 69.3% of Americans aged 26 to 40 years and in 66.5% of people aged 41 to 55 years. Moreover, the researchers noted their surprise on findings showing those older than 56 years to be at a distinct risk of sleep disorders as well (69.4%).

Common sleep disorders found in the study cohort included insomnia (64.3%), sleep apnea (14%), sleep paralysis (7.6%), parasomnias (6.7%), restless legs syndrome (5.2%), and narcolepsy (2.2%). When assessing how long those with sleep disorders spend in front of a bright screen per day, the maximum amount of time was found to be 20 hours. Across the study cohort, 5 hours was the average sleep time per night among Americans with sleep disorders.

Accounting for sociodemographic factors, nearly 8 in 10 (76.5%) of Americans living in urban areas reported sleep disorders compared with 70.2% of suburban citizens and 73% of rural citizens. Additionally, shift work was noted as a significant catalyst for sleep disorder risk, with 81.9% of shift workers found to have sleep disorders compared with 73% of full-time workers and 72% of freelancers.

So, how has technology benefited those with sleep disorders?

In the study, 33.6% of Americans switched to a smart bed or mattress as a solution for their sleep problems, with another 32.7% seeking support via sleep apps. Assessing preference of sleep interventions, 35.9% of participants would prefer to use sleep and meditation apps to treat their sleep disorders.

Wearables and fitness trackers were also found to be utilized by 15.4% of participants, with 7.1% saying they would opt for these devices in managing their sleep problems. Environmental monitoring devices, such as air purifiers, light emitting devices, and temperature controlling devices were also under consideration by 34.1% of the study cohort.

For those with sleep apnea (n = 107), continuous positive airway pressure therapy was used by 15.8% of them to treat their disorder, while 41% decided to use sleeping pills.

Related Videos
Michael Thorpy, MD, Albert Einstein College of Medicine and Montefiore Medical Center.
Dr Michael Thorpy
Dr. Michael Thorpy
Sheila Garland, PhD, MSc, Memorial University
Dayna Johnson, PhD, MPH, MSW, MS, Rollins School of Public Health at Emory University
Judite Blanc, PhD, Miller School of Medicine/University of Miami
Judite Blanc, PhD, Miller School of Medicine/University of Miami
Andrew McHill, PhD, Oregon Health and Science University
Dayna Johnson, PhD, MPH, MSW, MS, Rollins School of Public Health at Emory University
Sheila Garland, PhD, MSc, Memorial University
Related Content
© 2024 MJH Life Sciences
All rights reserved.